Supplier
Lincare Pharmacy Services INC.
Lincare Pharmacy Services INC. was paid $14.92M by Medicaid between Jan 2018 and Dec 2024, across 17 billing codes. Its largest line is J7605, Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms — 31% of everything it billed.
33Billing provider infoLINCARE PHARMACY SERVICES INC.
PINELLAS PARK, FL 33782
PINELLAS PARK, FL 33782
33aNPI1780748939assigned 12/21/2006
33bProvider typeMail Order Pharmacy
28Total paid$14.92M
24GClaims1,429,012
24DCodes billed17
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BARNHARD, JEFFREY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 110,565 | $1.14M | |
| 2019 | 193,247 | $1.72M | |
| 2020 | 292,762 | $3.10M | |
| 2021 | 261,812 | $3.40M | |
| 2022 | 234,093 | $2.67M | |
| 2023 | 219,324 | $1.81M | |
| 2024incomplete | 117,209 | $1.08M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms | 31% | 90,013 | 70,948 | $4.68M |
| J7606 | Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms | 24% | 56,224 | 45,017 | $3.56M |
| J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram | 13% | 52,794 | 14,995 | $1.98M |
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | 11% | 491,124 | 398,025 | $1.67M |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | 9.9% | 143,315 | 114,030 | $1.47M |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 4.7% | 243,651 | 198,842 | $708K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 3.9% | 280,363 | 228,113 | $582K |
| G0333 | Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary | <1% | 22,305 | 18,949 | $134K |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 35,761 | 28,344 | $54K |
| Q0514 | Pharmacy dispensing fee for inhalation drug(s); per 90 days | <1% | 6,279 | 5,609 | $42K |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 2,006 | 1,677 | $30K |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | <1% | 920 | 835 | $3K |
5 more codes
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 3,370 | $2K |
| E0570 | Nebulizer, with compressor | <1% | 554 | $989.22 |
| G0513 | Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service) | <1% | 16 | $59.40 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 303 | $54.65 |
| A7013 | Filter, disposable, used with aerosol compressor or ultrasonic generator | <1% | 14 | $2.02 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBARNHARD, JEFFREY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Founders Healthcare, LLC | Phoenix, AZ | $66.75M |
| Founders Healthcare, LLC | Tucson, AZ | $20.76M |
| Founders Healthcare, LLC | Las Vegas, NV | $18.86M |
| Lincare INC. | Greenwood, IN | $16.16M |
| Lincare INC. | Fort Wayne, IN | $13.95M |
| Lincare INC | Westerville, OH | $12.98M |
| Patient Support Services, INC | Texarkana, TX | $10.33M |
| Founders Healthcare, LLC | Glendale, AZ | $8.92M |
| Founders Healthcare LLC | Tempe, AZ | $7.47M |
| RCS Management Corp | Surprise, AZ | $5.55M |
| Lincare INC. | South Point, OH | $4.86M |
| Lincare INC | Moraine, OH | $4.56M |
| Lincare INC. | Asheville, NC | $4.35M |
| Lincare INC. | Cincinnati, OH | $4.34M |
| Lincare INC | Terre Haute, IN | $4.31M |
| Lincare INC | Bridgeport, WV | $3.97M |
| Lincare INC. | Madison, IN | $3.66M |
| Lincare INC. | Winston-salem, NC | $3.55M |
| Lincare INC. | Largo, FL | $3.08M |
| Lincare INC. | Concord, CA | $2.75M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.